Shingles: Immune Effects of Tai Chi

Aging Clinical Trial

Official title:

Behavioral Intervention for Herpes Zoster Risk in Aging

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00118885
• Other study ID #: AG0029
• Secondary ID: R01AG018367
• Status: Completed
• Phase: Phase 2
• First received: July 8, 2005
• Last updated: December 9, 2009
• Start date: July 2001
• Est. completion date: December 2004

Study information

• Verified date: November 2006
• Source: National Institute on Aging (NIA)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The purpose of this trial is to evaluate the effects of Tai Chi Chih versus Health Education on shingles immunity in older adults as measured by unstimulated and vaccine-stimulated responses. The secondary goal of the study is to determine the effects of Tai Chi Chih versus Health Education on measures of health functioning, depressive symptoms, and health behaviors in the elderly.

Description:

Shingles, also known as herpes zoster (HZ), is more common in older persons due to the weakening of the immune system with advancing age. Psychosocial stresses in the older adult also correlate with the decline in immunity. In addition, preliminary data indicate that the presence of depressive symptoms in older adults is associated with a decline in the response to varicella zoster virus (VZV) vaccination. Taken together, the untoward effects of age and depressive symptoms on VZV immunity raise the question as to whether a behavioral intervention might augment VZV specific immunity in the older adult.

Preliminary data has shown that administration of a relaxation-response based intervention, Tai Chi Chih (TCC), results in improvements in health functioning and VZV immunity in older adults as compared to a control group. TCC is a slow moving meditation comprised of twenty separate standardized movements for use in elderly populations. By standardization of training and practice schedules, TCC offers an important advantage over prior relaxation response based therapies. This controlled trial has 3 goals:

1. determine whether the practice of TCC for 16 weeks influences unstimulated- and vaccine-stimulated VZV specific immunity in adults 60 years of age and older;

2. demonstrate that TCC can produce significant changes in psychological adaptation, health behaviors, and health functioning and well-being;

3. assess whether changes in psychological adaptation, health behaviors, and health functioning correlate with changes in VZV immunity following TCC in older adults.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 140
• Est. completion date: December 2004
• Est. primary completion date: December 2004
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 60 Years to 90 Years

Eligibility

Inclusion Criteria:

• Older than 60 years of age at time of entry

• History of varicella or long term (>30 years) residence in the continental USA

• Accessible geographically

Exclusion Criteria:

• Immunosuppression resulting from neoplastic disease, corticosteroids or other therapy

• Significant underlying illness that would be expected to prevent completion of the study; any other condition (e.g. extensive psoriasis, chronic pain syndrome, cognitive impairment, severe hearing loss) that in the opinion of the investigator might interfere with the required evaluations

• Not ambulatory (bed-ridden)

• Prior HZ or prior receipt of varicella vaccine

• Allergic sensitivity to neomycin

• Receipt of immune globulin or other blood product within 3 months before the study period

• Receipt of other immunizations (e.g., hepatitis B vaccine) within 1 month of immunization

• Women who are not post-menopausal

• Acutely depressed or a suicidal risk

• Unable to commit to intervention schedule

• No history of varicella or varicella vaccination or no evidence of VZV immunity

• Contact with immunosuppressed individuals or pregnant women who do not have a history of chickenpox

• Active infections such as tuberculosis

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Aging
• Herpes Zoster

Intervention

Behavioral:
• Tai Chi Chih

Locations

Country	Name	City	State
United States	Cousins Center for Psychoneuroimmunology, UCLA Neuropsychiatric Institute	Los Angeles	California

Sponsors (2)

Lead Sponsor	Collaborator
National Institute on Aging (NIA)	National Center for Complementary and Integrative Health (NCCIH)

Country where clinical trial is conducted

United States, 

References & Publications (4)

Irwin M, Pike J, Oxman M. Shingles Immunity and Health Functioning in the Elderly: Tai Chi Chih as a Behavioral Treatment. Evid Based Complement Alternat Med. 2004 Dec;1(3):223-232. Epub 2004 Dec 1. — View Citation

Irwin MR, Pike JL, Cole JC, Oxman MN. Effects of a behavioral intervention, Tai Chi Chih, on varicella-zoster virus specific immunity and health functioning in older adults. Psychosom Med. 2003 Sep-Oct;65(5):824-30. — View Citation

Miller GE, Cohen S. Psychological interventions and the immune system: a meta-analytic review and critique. Health Psychol. 2001 Jan;20(1):47-63. — View Citation

Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005 Jun 2;352(22):2271-84. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	varicella zoster specific immunity
Secondary	measures of health status including SF-36 scores, depressive symptoms, and health behaviors